21
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Growth Factor Administration Following Autologous Peripheral Blood Progenitor Cell Transplantation

, , , , , , , , & show all
Pages 65-75 | Received 28 Oct 1996, Published online: 01 Jul 2009

References

  • Frei E., III, Canellos G. P. Dose a critical factor in cancer chemotherapy. American Journal of Medicine 1980; 69: 585–594
  • Frei E., III, Antman K., Teicher B., Eder P., Schnipper L. Bone marrow autotransplantation for solid tumors-prospects. Journal of Clinical Oncology 1989; 7: 515–526
  • Menichella G., Pierelli L., Foddai M. L., Paoloni A., Vittori M., Serafini R., Benedetti Panici P., Scambia G., Baiocchi G., Greggi S., Laurelli S., Salerno G., Mancuso S., Mango G., Bizzi B. Autologous blood stem cell harvesting and transplantation in patients with advanced ovarian cancer. British Journal of Haematology 1991; 79: 444–450
  • To L. B., Roberts M. M., Haylock D. N., Dyson P. G., Branford A. L., Thorp D., Ho J. Q. K., Dart G. W., Horvath N., Davy M. L. J., Olweny C. L. M., Abdi M., Juttner C. A. Comparison of haematological recovery times and supportive care requirements for autologous recovery phase peripheral blood stem cell transplants, autologus bone marrow transplants and allogeneic bone marrow transplant. Bone Marrow Transplantation 1992; 9: 271–284
  • Henon P. R., Liang H., Beck-Wirth G., Eisenmann J. C., Lepers M., Wunder E., Kandel G. Comparison of hematopoietic and immune recovery after autologous bone marrow or blood stem cell transplants. Bone Marrow Transplantation 1992; 9: 285–291
  • Pierelli L., Iacone A., Quaglietta A. M., Nicolucci A., Menichella G., Benedetti Panici P., D'Antonio D., De Laurenzi A., De Rosa L., Fioritoni G., Indovina A., Leone G., Majolino I., Montuoro A., Scime' R., Torlontano G. Haemopoietic reconstitution after autologous blood stem cell transplantation in patients with malignancies: a mul-ticentre retrospective study. British Journal of Haematology 1994; 86: 70–75
  • Beyer J., Schwella N., Zingsem J., Stronscheer I., Schwaner I., Oettle H., Serke S., Huhn D., Siegert W. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison. Journal of Clinical Oncology 1995; 13: 1328–1335
  • Ayash L. J., Elias A., Wheeler C., Reich E., Schwartz G., Mazanet R., Tepler I., Warren D., Lynch C., Gonin R., Schnipper L., Frei E., III, Antman K. Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study. Journal of Clinical Oncology 1994; 12: 37–44
  • Peters W. P., Rosner G., Ross M., Vredenburgh J., Meisenberg B., Gilbert C., Kurtzherg J. Comparative effects of granulocyte-macrophage colony-stimdating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 1993; 81: 1709–1719
  • Gianni A. M., Tarella C., Bregni M., Siena S., Lombardi F., Gandola L., Caracciolo D., Stern A., Bonadonna G., Boccadoro M., Pileri A. High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma. Journal of Clinical Oncology 1994; 12: 503–509
  • Benedetti Panici P., Greggi S., Scambia G., Salerno M. G., Baiocchi G., Laurelli G., Menichella G., Pierelli L., Foddai M. L., Serafini R., Bizzi B., Mancuso S. Very high-dose chemotherapy with autologous peripheral stem cell support in advanced ovarian cancer. European Journal of Cancer 1995; 31A: 1987–1992
  • Gianni A. M., Siena S., Bregni M., Tarella C., Stem A. C., Pileri A., Bonadonna G. Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation. Lancet 1989; 2: 580–585
  • Elias A. D., Ayash L., Anderson K. C., Hunt M., Wheeler C., Schwartz G., Tepler I., Mazanet R., Lynch C., Pap S., Pelaez J., Reich E., Critchlow J., Demetri G., Bibbo J., Schnipper L., Griffin J. D., Frei E., III, Antman K. H. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 1992; 79: 3036–3044
  • Sica S., Salutari P., Di Mario A., Rutella S., Ortu-LaBarbera E., Storti S., De Stefano V., Menichella G., Pierelli L., Zini G., Leone G. Autologous transplantation of peripheral blood progenitor cells mobilized by chemotherapy with or without G-CSF (filgrastim) in resistant lymphoproliferative diseases: enhanced hemopoietic recovery with filgrastim primed progenitors. Haematologica 1993; 78: 383–388
  • Menichella G., Pierelli L., Scambia G., Salerno G., Benedetti Panici P., Foddai M. L., Serafini R., Puglia G., Lai M., Ciarli M., Mancuso S., Bizzi B. Low-dose cyclophosphamide in combination with cisplatin or epirubicin plus rhG-CSF allows adequate collection of PBSC for autotransplantation during adjuvant therapy for high-risk cancer. Bone Marrow Transplantation 1994; 14: 907–912
  • Advani R., Chao N. J., Horning S. J., Blume K. G., Ahn D. K., Lamhorn K. R., Fleming N. C., Bonnem E. M., Greenberg P. L. Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hematopoietic stem cell transplantation for lymphoma. Annals of Internal Medicine 1992; 116: 183–189
  • Bensinger W. I., Longin K., Appelbaum F., Rowley S., Weaver C., Lilleby K., Gooley T., Linch M., Higano T., Klarnet J., Chauncey T., Storb R., Buckner C. D. Peripheral blood stem cells (PBSCs) collected after recombi-nant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. British Journal of Haematology 1994; 87: 825–831
  • Bensinger W., Appelbaum F., Rowley S., Storh R., Sanders J., Lilleby K., Gooley T., Demirer T., Schiffman K., Weaver C., Clift R., Chauncey T., Klarnet J., Montgomery P., Petersdorf S., Weiden P., Witherspoon R., Buckner C. D. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. Journal of Clinical Oncology 1995; 13: 2547–2555
  • Shimazaki C., Oku N., Uchiyama H., Yagamata N., Tatsumi T., Hirata T., Ashishara E., Okawa K., Goto H., Inaba T., Fujita N., Hamyama H., Nakagawa M. Effect of granulocyte colony-stimulating factor on hematopoietic recovery after peripheral blood progenitor cell transplantation. Bone Marrow Transplantation 1994; 13: 271–275
  • Spitzer G., Adkins R. D., Spencer V., Dunphy F. R., Petruska P. J., Velasquez W. S., Bowers C. E., Kronmueller N., Niemeyer R., McIntyre W. Randomized study of growth factors post-peripheral-blood stem-cell transplant: neutrophil recovery is improved with modest clinical benefit. Journal of Clinical Oncology 1994; 12: 661–670
  • Klumpp T. R., Mangan K. F., Goldberg S. L., Pearlman E. S., Macdonald J. S. Granulocyte colony-stimulating factor accelerates neutrophil engraftment following peripheral-blood stem-cell transplantation: a prospective, randomized trial. Journal of Clinical Oncology 1995; 13: 1323–1327
  • Graber S. E., Krantz S. B. Erythropoietin and the control of red blood cell production. Annual Review of Medicine 1978; 29: 51–66
  • Souza L. M., Boone T. C., Gabrilove J., Lai P. H., Zsebo K. M., Murdock D. C., Chazin V. R., Bruszewsky J., Lu H., Chen K. K., Barendst J., Platzer E., Moore M. A. S., Mertelsman R., Welte K. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986; 232: 61–65
  • Fauser A. A., Messner H. A. Identification of megakaryocytes, macrophages and eosinophils in colonies of human bone marrow containing neutrophilic granulocytes and erythrohlasts. Blood 1979; 53: 1023–1027
  • Clark D. A., Dessypris E. N. Effects of recombinant erythropoietin on murine megakaryocytic colony formation in vitro. Journal of Laboratory and Clinicnl Medicine 1986; 108: 423–429
  • Dessypris E. N., Gleaton J. H., Armstrong O. L. Effect of recombinant erythropoietin on human marrow megakaryocyte colony formation in vitro. British Journal of Haemarology 1987; 65: 265–269
  • Ishibashi T., Koziol J. A., Burnstein S. A. Human recombinant erythropoietin promotes differentiation of murine megakaryocytes in vitro. Journal of Clinicol investigation 1987; 79: 286–289
  • McDonald T. P., Cottrell M. P., Clift R. E., Cullen W. C., Lin F. K. High doses of recombinant erythropoietin stimulate platelet production in mice. Experimental Hematology 1987; 15: 719–721
  • Dessypris E. N., Graber S. E., Krantz S. B., Stone W. J. Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. Blood 1988; 72: 2060–2062
  • Kessinger A., Bishop M. R., Jackson J. D., O'Kane-Murphy B., Vose J. M., Bierman P. J., Reed E. C., Warkentin P. I., Armitage J. O., Sharp J. G. Erythropoietin for mobilization of circulating progenitor cells in patients with previously treated relapsed malignancies. Experimental Hematology 1995; 23: 609–612
  • Pettengell R., Woll P. J., Chang J., Coutinho L., Testa N. G., Crowther D. Effects of erythropoietin on mobilisation of haemopoietic progenitor cells. Bone Marrow Transplantation 1994; 14: 125–130
  • Pierelli L., Menichella G., Scambia G., Teofili L., Iovino M. S., Serafini R., Benedetti Panici P., Salemo G., Rumi C., Zini G., d'Onofrio G., Leone G., Mancuso S., Bizzi B. In vitro and in vivo effects of recombinant human erythropoietin plus recombinant human G-CSF on human haemopoietic progenitor cells. Bone Marrow Transplantation 1994; 14: 23–30
  • Olivieri A., Oftidani M., Cantori I., Ciniero L., Ombrosi L., Masia M. C., Brunori M., Montroni M., Leoni P. Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization. Bone Marrow Transplantation 1995; 16: 765–770
  • Bessho M., Toyoda A., Itoh Y., Sakata T., Kawai N., Jinnai I., Saito M., Hirashima K. Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEPO) in severe aplastic anaemia. British Journal of Haematology 1992; 80: 409–411
  • Negrin R. S., Stein R., Vardiman J., Doherty K., Comwell J., Krantz S., Greenberg P. L. Treatment of the anemia of rnyelodisplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. Blood 1993; 82: 731–743
  • Locatelli F., Zecca M., Bonetti F., Ponchio L., Giorgiani G., De Stefano P., Cazzola M. Combined administration of erythropoietin and granulocyte colony-stimulating factor (G-CSF) to children after allogeneic bone marrow transplantation (BMT) accelerates trilineage marrow reconsti-tution. Blood 1993; 82(Suppl.l)285
  • Pene R., Appelbaum F. R., Fisher L., Lilleby K., Nemunaitis J., Storb R., Buckner C. D. Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation. Bone Marrow Transplantation 1993; 11: 219–222
  • Chao J. N., Schriber J. R., Long G. D., Negrin R. S., Catolico M., Brown B. W., Miller L. L., Blume K. G. A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. Blood 1994; 83: 2823–2828

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.